Skip to content

Medtronic

US · MDT #176 by market cap Listed 1970
99.94 -0.67 -0.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 100.82 +0.21%
After-hours 99.68 -0.26%
Overnight 100.67 +0.06%
104.9673.0999.942026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on MDT?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +5.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 1.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 24.6x Better than 31%
Forward P/E 21.6x Better than 31%
Price / Sales 3.5x Better than 35%
P/E vs own 5-yr range 33rd pctl Better than 74%
Growth B-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 5.2% Better than 47%
Net income CAGR (3Y) 8.5% Better than 56%
Free cash flow CAGR (3Y) 5.8% Better than 47%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 65.0% Better than 79%
Operating margin 18.8% Better than 74%
Net margin 13.2% Better than 68%
Return on equity 9.8% Better than 51%
Return on invested capital 7.0% Better than 55%
Momentum A-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 7.1% Better than 86%
6-month return 28.3% Better than 89%
12-month return (ex latest month) -3.4% Better than 30%
Distance below 52-week high 5.9% Better than 93%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.1x Better than 59%
Debt to assets 30.1% Better than 41%
Interest coverage 9.6x Better than 72%
Free cash flow / net income 113.0% Better than 47%
Analyst View C-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 60.0% Better than 36%
Upside to average target 7.3% Better than 11%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -2.84%
1M +5.61%
3M +8.28%
6M +29.04%
YTD +5.83%
1Y +3.08%
3Y +45.51%
5Y -0.77%

Key statistics

Price & volume

Prev close
100.61
Open
101.42
Day range
99.59 - 102.61
Avg price
100.60
Volume
9.03M
Turnover
908.85M
Amplitude
3.00%
52-week range
72.06 - 106.20

Valuation

P/E
26.79
P/E (TTM)
24.62
P/B
2.54
EPS
3.73
Net profit
4.77B
Net assets
50.23B

Share structure

Market cap
127.84B
Float cap
127.61B
Shares out
1.28B

Dividend & listing

Dividend (TTM)
2.85
Listing date
1970-01-01
52-week range 82% of range
72.06 106.20

5.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-311.18M net over the window

Short interest

Shares short
22.95M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Medtronic (MDT)?

Medtronic last traded at 99.94. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Medtronic's market cap?

About 127.84B.

What is the P/E ratio of Medtronic?

The trailing twelve-month P/E is 24.62, below its own 5-year average of 26.59 — toward the bottom of its historical range (32.99% percentile). See the Valuation tab for the full history.

Does Medtronic pay a dividend?

Yes. The trailing dividend yield is 2.85%. The 2025 payout was up 1.4% from 2024. See the Dividends tab for the full payment history.

Is Medtronic a buy according to analysts?

The consensus of 20 analysts is a Buy rating, with an average 12-month price target of 107.24, which implies 7.3% upside from the current price. This is not investment advice.

What is Medtronic's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Medtronic a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Medtronic discussion 0 comments

Add a comment